Verapamil for blood sugar issues in cystic fibrosis
Part of Digestive system, Genetic & congenital, Lungs & breathing clinical trials.
This trial tests if Verapamil, a blood pressure medication, can help improve blood sugar control in people with cystic fibrosis who have early diabetes or abnormal glucose tolerance. It may offer a new way to manage these issues.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 14 years or older.
- You must have a confirmed diagnosis of cystic fibrosis.
- You must need pancreatic enzymes (PERT) because your pancreas doesn't work well.
- You must have been diagnosed with abnormal glucose tolerance or cystic fibrosis-related diabetes within the last 3 months.
- You must be willing to take Verapamil pills up to 360 mg each day.
- You cannot have severe lung disease (FEV1 below 50%).
- You cannot have a BMI under 18 or weigh under 50 kg (110 lbs).
- You cannot be pregnant or planning pregnancy in the next 6 months.
- You cannot have used IV antibiotics for a CF flare-up in the last month.
- You cannot currently use insulin or other diabetes medications.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether a low glycemic load (a specific way of choosing carbohydrates) improves blood sugar control and body composition in adults with cystic fibrosis–related diabetes. It may help reduce blood sugar problems and support healthier weight and body measurements.
This trial tests whether adding metformin can improve blood-sugar control and related lung cell function in adults who have cystic-fibrosis–related diabetes (CFRD) and are already taking CFTR modulator therapy. It may help if your diabetes is still not well controlled despite those CF medicines.
This study tests a drug called dorzagliatin to see if it can help control blood sugar in adults with cystic fibrosis who have pancreatic insufficiency and abnormal glucose tolerance.
This study looks at how the body handles sugar in people with cystic fibrosis related diabetes. Researchers want to learn more about glucose metabolism to improve care for people with CFRD.
This trial studies whether changing eating habits—especially added sugar intake—affects health in adults with cystic fibrosis. It may help by testing a diet approach aimed at better outcomes related to metabolism and overall health.
This study looks at how long-term diabetes affects people with cystic fibrosis. It helps researchers understand complications and improve care.
Hear when a new Cystic Fibrosis-related Diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.